Advanced Search

Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2007 August;59(4) > Minerva Pediatrica 2007 August;59(4):299-305



A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532

Frequency: Bi-Monthly

ISSN 0026-4946

Online ISSN 1827-1715


Minerva Pediatrica 2007 August;59(4):299-305


Telecare for teenagers with type 1 diabetes: a trial

Cadario F. 1, Binotti M. 1, Brustia M. 2, Mercandino F. 1, Moreno G. 1, Esposito S. 1, Baldelli R. 1, Bona G. 1

1 Department of Paediatrics Maggiore della Carità Hospital Università del Piemonte Orientale, Novara, Italy
2 Department of Chemistry Maggiore della Carità Hospital, Novara, Italy

Aim. The aim of this paper was to test in teenagers with type 1 diabetes mellitus (T1DM) the Glucobeeb (Gb), a web based tool to support the diabetes care.
Methods. Gb transfers glucometer’s data by phone and Internet to the PC of practitioner in files dedicated to each patient; the response returns to patient as 1-min vocal message. From outpatients paediatric clinic 28 teenagers (mean 14.8 years, range 10-20, male 14) with T1DM on multiple daily injections insulin therapy, with glicated haemoglobin (HbA1c) over 7% and >2 years’ duration of the disease (9.1 years, range 2-15), were consequently randomized to telecare (glucometer transmission with feedback, group A) or control (standard communication by phone and face-to-face visits, group B). Glycaemia was tested four times per day and data transmitted every 2 weeks; clinician feedback returned within the following week. Two controls were excluded after randomization. Outcomes of 14 patients of A were compared with 12 of B.
Results. In intervention group average HbA1c% decreased from baseline at 3 and 6 months in comparison with controls (9.5, 9.0, 9.1, vs 9.1, 9.4, 9.4 respectively). Controls after 6 months were introduced to Gb, and similar trend of HbA1c was observed in the following examinations at 3 and 6 month (9.4, 8.9, 8.7). Then, in both groups HbA1c after 12 months of Gb increased, and after 18 reduced (A: 9.2, and 8.8, B 9.1 and 8.5 respectively). The enhancement of HbA1c from baseline to end was significant (P=0.01).
Conclusion. The tool improves metabolic control in teenagers with T1DM.

language: English


top of page